Greater Miami is rapidly emerging as an international biotech hot spot—as capital, talent, and infrastructure converge to transform the region from a tourism-driven economy into a globally connected life sciences innovation hub.
Daniel Teper, PharmD, MBA
Advertisement
Founder and CEO of NAYA Therapeutics.
Articles by Daniel Teper, PharmD, MBA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Pharma Leadership Roundup: Sarepta Therapeutics CEO Announces Retirement, Rivus Pharmaceuticals Appoints New CEO
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
4
What Does the Rollout of Trump Rx Reveal?
5